Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Helen M. Boudreau currently holds 81,000 shares of Cara Therapeutics, Inc. (CARA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Helen M. Boudreau has been a net seller of CARA stock. They have purchased $0 and sold $131.6K worth of shares.
Helen M. Boudreau's most recent insider trade was on May 29, 2026, when they sold 81,000 shares at $0.00 per share.
Helen M. Boudreau serves as Executive at Cara Therapeutics, Inc. (CARA). They have executed 11 insider transactions totaling $131.6K over their tenure at the company.
Helen M. Boudreau holds the position of Executive at Cara Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Helen M. Boudreau has shown a selling trading pattern, with $0 in total purchases and $131.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Helen M. Boudreau was on Nov 25, 2025, when they sold $527.4K worth of PINC shares. This transaction involved 18,668 shares at $28.25 per share.
Helen M. Boudreau currently owns 81,000 shares of Cara Therapeutics, Inc. (CARA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Helen M. Boudreau's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Helen M. Boudreau has 11 Form 4 filings on record as an insider at Cara Therapeutics, Inc..
Set alerts for Helen M. Boudreau and 40,000+ other insiders.